Search

Search Constraints

You searched for: Author/Creator Silva, Clovis A

Search Results

1. 605 The Systemic Lupus Erythematosus International Collaborating Clinics (SLICC), American College of Rheumatology (ACR), and Lupus Foundation of America (LFA) Damage Index Revision – Item Generation Phase. (14th December 2022)

2. Air pollution influence on serum inflammatory interleukins: A prospective study in childhood-onset systemic lupus erythematous patients. (December 2021)

4. CS-10 Criteria for clinically relevant improvement in children & adolescents with childhood-onset systemic lupus erythematosus. (August 2018)

5. Defining renal remission in an international cohort of 248 children and adolescents with lupus nephritis. (9th October 2021)

6. Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial. Issue 6 (16th May 2014)

7. EULAR/PRINTO/PRES criteria for Henoch–Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Issue 5 (22nd April 2010)

8. Immunogenicity and safety of the 2009 non-adjuvanted influenza A/H1N1 vaccine in a large cohort of autoimmune rheumatic diseases. Issue 6 (2nd May 2011)

9. Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective study. (February 2022)

10. Immunogenicity, safety, and antiphospholipid antibodies after SARS-CoV-2 vaccine in patients with primary antiphospholipid syndrome. (July 2022)